Cargando…

A Differentiation-Related Gene Prognostic Index Contributes to Prognosis and Immunotherapy Evaluation in Patients with Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is the most common gastrointestinal tumor with a poor prognosis, which is associated with poor differentiation of tumor cells. However, the potential value of cell differentiation-related molecules in predicting the benefit and prognosis of immune checkpoint inhibitors...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Jingjing, Liu, Tao, Liu, Zhenhua, Xiao, Chuan, Du, Jun, Zuo, Shi, Li, Haiyang, Gu, Huajian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367442/ https://www.ncbi.nlm.nih.gov/pubmed/35892599 http://dx.doi.org/10.3390/cells11152302

Ejemplares similares

Construction of a ceRNA Network and Analysis of Tumor Immune Infiltration in Pancreatic Adenocarcinoma
por: Xiao, Jingjing, et al.
Publicado: (2021)

A novel ferroptosis-related gene prognostic index for prognosis and response to immunotherapy in patients with prostate cancer
por: Wang, Yuliang, et al.
Publicado: (2022)

Identification of cuprotosis-mediated subtypes, the development of a prognosis model, and influence immune microenvironment in hepatocellular carcinoma
por: Xiao, Jingjing, et al.
Publicado: (2022)

The Prognostic Model Established by the Differential Expression Genes Based on CD8(+) T Cells to Evaluate the Prognosis and the Response to Immunotherapy in Osteosarcoma
por: Chen, Yu, et al.
Publicado: (2023)

Circulating immune index predicting the prognosis of patients with hepatocellular carcinoma treated with lenvatinib and immunotherapy
por: Guo, De-Zhen, et al.
Publicado: (2023)

Prognostic Nutritional Index and Systemic Immune-Inflammation Index Predict the Prognosis of Patients with HCC
por: Wang, Dong, et al.
Publicado: (2020)

A Lamin Family-Based Signature Predicts Prognosis and Immunotherapy Response in Hepatocellular Carcinoma
por: Yang, Yongyu, et al.
Publicado: (2022)

Hepatocellular carcinoma cell differentiation trajectory predicts immunotherapy, potential therapeutic drugs, and prognosis of patients
por: Qiu, Jun, et al.
Publicado: (2023)

Prognostic Significance of the L3 Skeletal Muscle Index and Advanced Lung Cancer Inflammation Index in Elderly Patients with Esophageal Cancer
por: Tan, Xiang, et al.
Publicado: (2021)

Glycometabolism-related gene signature of hepatocellular carcinoma predicts prognosis and guides immunotherapy
por: Yu, Lihua, et al.
Publicado: (2022)

STING pathway contributes to the prognosis of hepatocellular carcinoma and identification of prognostic gene signatures correlated to tumor microenvironment
por: Pu, Zhangya, et al.
Publicado: (2022)

Development of an immune-related prognostic index associated with hepatocellular carcinoma
por: Hu, Bo, et al.
Publicado: (2020)

Lipid metabolism of hepatocellular carcinoma impacts targeted therapy and immunotherapy
por: Feng, Xiao-Chen, et al.
Publicado: (2023)

TFCP2 Genetic Polymorphism Is Associated with Predisposition to and Transplant Prognosis of Hepatocellular Carcinoma
por: Liu, Zhikun, et al.
Publicado: (2017)

Immunotherapies for advanced hepatocellular carcinoma
por: Sun, Li-Yang, et al.
Publicado: (2023)

A Powerful Nomogram Based on the Novel D-Index to Predict Prognosis After Surgical Resection of Hepatocellular Carcinoma
por: Du, Xia, et al.
Publicado: (2021)

Value of the preoperative prognostic nutritional index for the evaluation of patient prognosis after radical gastrectomy
por: Wang, Lili, et al.
Publicado: (2020)

A Metabolism-Related Gene Prognostic Index for Prediction of Response to Immunotherapy in Lung Adenocarcinoma
por: Tang, Bo, et al.
Publicado: (2022)

Identification of Ferroptosis-Related Biomarkers for Prognosis and Immunotherapy in Patients With Glioma
por: Shi, Junfeng, et al.
Publicado: (2022)

Unveiling the Role of Tumor-Infiltrating T Cells and Immunotherapy in Hepatocellular Carcinoma: A Comprehensive Review
por: Chen, Xiaokun, et al.
Publicado: (2023)

Postoperative aspartate aminotransferase to platelet ratio index change predicts prognosis for hepatocellular carcinoma
por: Peng, Wei, et al.
Publicado: (2016)

Combined prognostic nutritional index and albumin-bilirubin grade to predict the postoperative prognosis of HBV-associated hepatocellular carcinoma patients
por: Liang, Xie, et al.
Publicado: (2021)

Prediction of 3-year recurrence rate of hepatocellular carcinoma after resection based on contrast-enhanced CT: a single-centre study
por: Lv, Chao, et al.
Publicado: (2023)

A Prognostic Model Based on NSUN3 Was Established to Evaluate the Prognosis and Response to Immunotherapy in Liver Hepatocellular Carcinoma
por: Zhu, Jianlin, et al.
Publicado: (2023)

Development of a prognostic model based on anoikis-related genes for predicting clinical prognosis and immunotherapy of hepatocellular carcinoma
por: Pang, Mu, et al.
Publicado: (2023)

ZCCHC17 Served as a Predictive Biomarker for Prognosis and Immunotherapy in Hepatocellular Carcinoma
por: Liu, Fahui, et al.
Publicado: (2022)

Identification of cancer-associated fibroblasts signature for predicting the prognosis and immunotherapy response in hepatocellular carcinoma
por: Ye, Jianzhong, et al.
Publicado: (2023)

Comprehensive analysis of prognostic value and immunotherapy prospect of brain cytoplasmic RNA1 in hepatocellular carcinoma
por: Han, Xiao-Yong, et al.
Publicado: (2023)

Analysis of the role of m6A and lncRNAs in prognosis and immunotherapy of hepatocellular carcinoma
por: Xu, Yan, et al.
Publicado: (2022)

Gene expression profiles contribute to robustly predicting prognosis in hepatocellular carcinoma
por: Liu, Long, et al.
Publicado: (2023)

CTNNB1 Alternation Is a Potential Biomarker for Immunotherapy Prognosis in Patients With Hepatocellular Carcinoma
por: Chen, Lin, et al.
Publicado: (2021)

Comprehensive analysis of anoikis‐related lncRNAs for predicting prognosis and response of immunotherapy in hepatocellular carcinoma
por: Du, Sihao, et al.
Publicado: (2023)

Immune-related gene-based prognostic index for predicting survival and immunotherapy outcomes in colorectal carcinoma
por: Liang, Zhongqing, et al.
Publicado: (2022)

Microenvironment characterization and multi-omics signatures related to prognosis and immunotherapy response of hepatocellular carcinoma
por: Liu, Furong, et al.
Publicado: (2020)

Identification of Immune-Related Genes for Establishment of Prognostic Index in Hepatocellular Carcinoma
por: Li, Yinfang, et al.
Publicado: (2021)

An inflammation‐associated ferroptosis signature optimizes the diagnosis, prognosis evaluation and immunotherapy options in hepatocellular carcinoma
por: Ruan, Wan‐Yuan, et al.
Publicado: (2023)

Author Correction: Combined prognostic nutritional index and albumin-bilirubin grade to predict the postoperative prognosis of HBV-associated hepatocellular carcinoma patients
por: Liang, Xie, et al.
Publicado: (2021)

Integrated Machine Learning and Bioinformatic Analyses Constructed a Novel Stemness-Related Classifier to Predict Prognosis and Immunotherapy Responses for Hepatocellular Carcinoma Patients
por: Chen, Dongjie, et al.
Publicado: (2022)

Identification and Validation of Prognosis-Related Necroptosis Genes for Prognostic Prediction in Hepatocellular Carcinoma
por: Gao, Xin, et al.
Publicado: (2022)

A necroptosis -related signature for predicting prognosis and immunotherapy in hepatocellular carcinoma
por: Fu, Xing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qog9nt1lfqfu2amfocddb34mpt